(a)

(c)

(b)

(d)

FIGURE 10.6 Schematic description of the different protocols tested (a), percentage of GFP positive cels (c), GFP production (b), and comparison of

the production when 0.5 EGE and 0.5 EGE (−2) are used (d).

Recombinant vaccines: Gag-based VLPs

253